Literature DB >> 19048425

Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate.

Anuj Garg1, S Singh, V U Rao, K Bindu, J Balasubramaniam.   

Abstract

This study investigated the effects of different classes of hydrophilic carriers (poly vinyl pyrrolidones [PVPs] [Plasdone K-25 and Plasdone S-630], cellulosic polymers [hydroxypropyl methyl cellulose and hydroxy propyl cellulose], and Sodium Alginate) on the solid state and dissolution rate of Raloxifene hydrochloride (R-HCl). Solid state characterizations of co-ground mixtures and physical mixtures in 1:1 and 1:2 ratios of drug to polymer were performed by employing laser diffractometer for particle size and differential scanning calorimetry (DSC) for solid state interactions. The results of particle size studies showed that only co-grinding with PVPs was more effective in the reduction of particle size than the milling of drug alone. DSC study indicated that the crystalline nature of the drug was reduced after co-grinding with PVPs when compared with their corresponding physical mixtures. The hydrophilic carriers other than PVPs did not reduce the crystalline nature of the drug significantly. X-ray diffraction and scanning electron microscopy were carried out for selected batches to confirm DSC results. Significant enhancement in dissolution rate and extent was observed with co-ground mixtures of drug and PVPs. Plasdone S-630 was found to be a better carrier for R-HCl in terms of achieving improvement in dissolution. In vitro dissolution data can be described by Hixson-Crowell model, indicating the drug release mechanism predominated by erosion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19048425     DOI: 10.1080/03639040802438365

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  7 in total

1.  Bioadhesive microspheres for bioavailability enhancement of raloxifene hydrochloride: formulation and pharmacokinetic evaluation.

Authors:  Ram K Jha; Sanjay Tiwari; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2011-05-12       Impact factor: 3.246

2.  Dissolution enhancement of atorvastatin calcium by co-grinding technique.

Authors:  Priyanka Prabhu; Vandana Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

3.  Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment.

Authors:  Noriaki Nagai; Fumihiko Ogata; Hiroko Otake; Yosuke Nakazawa; Naohito Kawasaki
Journal:  Int J Nanomedicine       Date:  2018-09-06

4.  Porous Microparticles Containing Raloxifene Hydrochloride Tailored by Spray Freeze Drying for Solubility Enhancement.

Authors:  Seyyed Pouya Hadipour Moghaddam; Sajjad Farhat; Alireza Vatanara
Journal:  Adv Pharm Bull       Date:  2018-06-19

5.  Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.

Authors:  Manal A Elsheikh; Yosra S R Elnaggar; Eman Y Gohar; Ossama Y Abdallah
Journal:  Int J Nanomedicine       Date:  2012-07-18

6.  Preliminary study of nanonized lamotrigine containing products for nasal powder formulation.

Authors:  Péter Gieszinger; Ildikó Csóka; Edina Pallagi; Gábor Katona; Orsolya Jójárt-Laczkovich; Piroska Szabó-Révész; Rita Ambrus
Journal:  Drug Des Devel Ther       Date:  2017-08-23       Impact factor: 4.162

7.  Mg,Si-Co-Substituted Hydroxyapatite/Alginate Composite Beads Loaded with Raloxifene for Potential Use in Bone Tissue Regeneration.

Authors:  Katarzyna Szurkowska; Paulina Kazimierczak; Joanna Kolmas
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.